Press release
Systemic Psoriasis Therapeutics Market Key Trends and Opportunity Analysis 2020
Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/3086
Psoriasis may be classified into various types such as plaque psoriasis, scalp psoriasis, pustular psoriasis, psoriatic arthritis, guttate psoriasis, nail psoriasis, erythrodermic psoriasis and inverse psoriasis. Various treatments for psoriasis are oral medication, topical medication and biologics injections. Psoriasis can also be treating by phototherapy treatment which includes ultraviolet light therapy, laser treatment, tanning beds, psoralen +UVA and sunlight treatment. Psoriasis can occur in any part of the body and it is associated with other health conditions such as heart disease, diabetes and depression.
North America, followed by Europe, has the largest market for systemic psoriasis therapeutics due to emergence of novel therapies and rise in treatment seeking population in the region. Asia is expected to show high growth rate in the systemic psoriasis therapeutics market in next few years due to increase in the awareness of disease in the region.
Technological advancement, rise in number of psoriasis patients, development of novel drugs, increasing disease awareness and improvement in diagnostic methods are some of the key factors driving the growth for global systemic psoriasis therapeutics market. In addition, long-term treatment involving continuous uptake of biologics are expected to drive the market for systemic psoriasis therapeutics. However, adverse side effects associated with psoriatic drugs and economic downturns are some of the key factors restraining the growth for global systemic psoriasis therapeutics market.
Growing demographics and economies in the developing countries such as India and China are expected to offer high growth in systemic psoriasis therapeutics market in Asia. In addition, growing demand of novel therapies for psoriasis treatment is expected to develop good opportunity for global systemic psoriasis therapeutics market. However, safety concern associated with systemic psoriasis therapeutics is expected to lead a challenge for systemic psoriasis therapeutics market. Some of the major trends that have been observed for systemic psoriasis therapeutics market are increasing use of combination therapies for treating psoriasis, emergence of non-invasive psoriasis treatment and technological advancement in the field.
Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/3086
Some of the major companies operating in the global systemic psoriasis therapeutics market are AbbVie Inc., Stiefel Laboratories, Inc., Biogen Idec, Novartis AG, CELGENE CORPORATION, Takeda Pharmaceutical Company Limited, Pfizer Inc., Amgen Inc., Janssen Biotech, Inc. and Eli Lilly and Company.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
Telephone - +1-646-568-7751
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Systemic Psoriasis Therapeutics Market Key Trends and Opportunity Analysis 2020 here
News-ID: 936855 • Views: …
More Releases from Persistence Market Research
Global Warehouse Management Systems Market to Reach US$12.5 Bn by 2032
The global warehouse management systems (WMS) market is projected to grow from US$4.7 billion in 2025 to US$12.5 billion by 2032, registering a CAGR of 15.1%. The rapid growth of e-commerce, globalization of supply chains, and increasing demand for real-time inventory tracking are key drivers fueling this market. WMS software plays a critical role in streamlining warehouse operations, from receiving goods to shipping, ensuring accuracy, efficiency, and reduced operational costs.
North…
Global Home Security Systems Market to Reach US$ 76.9 Bn by 2032
The global home security systems market is projected to grow from US$47.6 billion in 2025 to US$76.9 billion by 2032, registering a CAGR of 7.2%. Increasing crime rates, rising property thefts, and growing urbanization are key factors driving demand for smarter and safer living environments. Both homeowners and businesses are seeking advanced security solutions that provide real-time monitoring, greater control, and enhanced protection against burglary, fire, and other threats.
North America…
Global Cargo Management Tech Market to Reach $11.4 Bn by 2032
The global cargo management technology solutions market is projected to grow from US$3.7 billion in 2025 to US$11.4 billion by 2032, registering a robust CAGR of 17.5%. The growth is fueled by the rapid expansion of e-commerce, increasing international trade, and rising demand for efficient logistics systems capable of handling large order volumes while ensuring timely deliveries. Businesses are increasingly seeking solutions that enhance operational efficiency, streamline supply chain processes,…
Digital Rights Management Market Trends and Growth Analysis 2025-2032
The global digital rights management (DRM) market is poised for significant growth, with its size expected to reach US$11.6 billion by 2032, up from US$5.5 billion in 2025, registering a robust CAGR of 11.2%. The increasing adoption of digital content across media, entertainment, and enterprise sectors has accelerated the demand for effective content protection solutions. As intellectual property rights become a focal point for businesses and consumers alike, the need…
More Releases for Psoriasis
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Psoriasis Market Size During the Forecast Period?
The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a…
Major Market Shift in Psoriasis Industry: Combination Therapy Is An Emerging Tre …
What Is the Forecasted Market Size and Growth Rate for the Psoriasis Market?
The market scope for psoriasis has seen substantial growth in the past years. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, with a compound annual growth rate (CAGR) of 11.1%. Factors such as epidemiology, patient awareness and education, along with healthcare infrastructure and access have contributed to the growth in the…
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally.
Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to…
Psoriasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Psoriasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Pipeline Review, H1 2017, provides an overview of the Psoriasis (Immunology) pipeline landscape.
Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up…
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It…
